Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$51.9

Avg closing price
Price range

3 Daniel Loeb Vertex Pharmaceuticals Trades

Daniel Loeb started to build up the position in Vertex Pharmaceuticals in Q2 2012 and continued to invest until Q3 2012. Since then they sold 700 Thousand shares. The investor sold all their shares in Q4 2012 and doesn't own any shares in Vertex Pharmaceuticals anymore.

Avg closing price
Price range
Sold -700 Thousand shares Q4 2012
Avg closing price $46.24
Price range $38.88 - $59.42
Increased shares by 40.0% (+200 Thousand shares) Q3 2012
Avg closing price $53.75
Price range $48.36 - $59.04
New holding (+500 Thousand shares) Q2 2012
Avg closing price $51.21
Price range $35.49 - $64.85

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!